News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,040 Results
Type
Article (5008)
Company Profile (17)
Press Release (220015)
Section
Business (82197)
Career Advice (461)
Deals (15041)
Drug Delivery (8)
Drug Development (19061)
Employer Resources (30)
FDA (3676)
Job Trends (3900)
News (120098)
Policy (7500)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14767)
ALS (19)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3693)
Artificial intelligence (40)
Autoimmune disease (3)
Automation (2)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (439)
Cardiovascular disease (22)
Career advice (392)
Career pathing (2)
CAR-T (31)
Cell therapy (102)
Cervical cancer (2)
Clinical research (16016)
Collaboration (165)
Compensation (167)
Complete response letters (2)
COVID-19 (301)
CRISPR (7)
C-suite (99)
Cystic fibrosis (16)
Data (504)
Depression (5)
Diabetes (40)
Diagnostics (2039)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40783)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37724)
Executive appointments (309)
FDA (3924)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (179)
Gene editing (15)
Generative AI (2)
Gene therapy (50)
GLP-1 (107)
Government (411)
Guidances (16)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7822)
IRA (3)
Job creations (1120)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (5)
Legal (2331)
Liver cancer (17)
Lung cancer (53)
Lymphoma (28)
Management (10)
Manufacturing (47)
MASH (27)
Medical device (3858)
Medtech (3859)
Mergers & acquisitions (7423)
Metabolic disorders (118)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (338)
NextGen: Class of 2025 (1674)
Non-profit (727)
Northern California (909)
Now hiring (2)
Obesity (52)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (14)
Parkinson's disease (26)
Partnered (4)
Patents (21)
Patient recruitment (27)
Peanut (5)
People (24574)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4774)
Phase II (6953)
Phase III (5545)
Pipeline (541)
Policy (8)
Postmarket research (625)
Preclinical (1868)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (67)
Real estate (1874)
Recruiting (8)
Regulatory (5111)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (25)
Series B (22)
Sickle cell disease (7)
Southern California (689)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1007)
Stomach cancer (1)
Supply chain (10)
Tariffs (3)
United States (6934)
Vaccines (36)
Venture capitalists (2)
Weight loss (20)
Women's health (1)
Date
Today (28)
Last 7 days (111)
Last 30 days (698)
Last 365 days (10027)
2025 (2862)
2024 (11027)
2023 (13193)
2022 (18658)
2021 (19678)
2020 (18238)
2019 (13205)
2018 (10205)
2017 (10001)
2016 (9156)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11444)
Australia (1607)
California (1908)
Canada (691)
China (70)
Colorado (80)
Connecticut (91)
Delaware (29)
Europe (24487)
Florida (268)
Georgia (33)
Idaho (23)
Illinois (111)
India (6)
Indiana (63)
Iowa (1)
Japan (67)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (220)
Massachusetts (1531)
Michigan (85)
Minnesota (137)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (15)
New Jersey (555)
New Mexico (5)
New York (467)
North Carolina (325)
North Dakota (2)
Northern California (909)
Ohio (55)
Oklahoma (5)
Oregon (3)
Pennsylvania (339)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (4)
Southern California (689)
Tennessee (38)
Texas (223)
Utah (59)
Virginia (44)
Washington D.C. (9)
Washington State (171)
West Virginia (2)
Wisconsin (21)
225,040 Results for "vystar corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Vystar Adds Vytex into RxAir Spin-off, Sets Spin-Off Record Date, Opens Opportunity for Reverse Merger Into Vystar/Rotmans
Vystar® Corporation announces that it plans to split into two companies via a dividend. In addition to the previously announced spin-off of RxAir® air purification and Fluid Energy Conversion subsidiaries into a separate, publicly traded company, Vystar plans to add a third subsidiary, Vytex® latex and rubber, into the spin-off.
February 23, 2022
·
7 min read
Business
Vystar appoints Dr. Byron Novosad to Board of Directors
Vystar® Corporation (OTCQB: VYST) has named Byron Novosad, DDS, to the Vystar Board of Directors, effective immediately.
February 23, 2021
·
4 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Biotech Beach
Vystar Partners with “Nothing in the Air” for RxAir Marketing, Advertising & Distribution
Vystar® Corporation’s RxAir® division has joined forces with a powerful new ally, Nothing in the Air, to market and distribute the RxAir ultraviolet light air purifier product line.
June 2, 2021
·
6 min read
Business
Vystar Posts Highest Revenue & Profit in Company History in First Quarter 2021
Vystar® Corporation reports milestone financial results for the first quarter of 2021 with record high revenue and profit for the first time in the company’s history.
May 24, 2021
·
7 min read
Genetown
Vystar Issues Corporate Update on Strategic Initiatives and the Impact of COVID-19 on Brands
Vystar Corporation, parent company of RxAir® UV light air purification products, Rotmans Furniture and Floor Covering, and Vytex® deproteinized rubber and latex, has managed numerous initiatives though the challenges of the COVID-19 pandemic and has emerged with a new and stronger supply chain, reliable manufacturing partners, an improved product offering and a growing market presence and distribution network.
February 1, 2021
·
10 min read
Press Releases
Quantum BioPharma Corporate Update
April 21, 2025
·
4 min read
Press Releases
CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller
April 17, 2025
·
7 min read
Press Releases
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
March 26, 2025
·
17 min read
Press Releases
Lobe Sciences Provides Corporate Update
April 7, 2025
·
8 min read
1 of 22,504
Next